European Market Report for Continuous Glucose Monitoring 2016 - MedCore

  • ID: 3846027
  • Report
  • Region: Europe
  • 77 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • Abbott
  • Ascensia
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Menarini
  • MORE
The European CGM market comprises the CGM system segment and the CGM sensor segment. The business model for CGM is similar to traditional blood glucose meters, where the CGM system is the base equipment and the majority of sales are made from the disposable sensor component, which is replaced every three to seven days depending on the manufacturer. The CGM market is still considered to be in its infancy, but the disposable sensors will be the most important revenue generator as the technology gains further acceptance.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Ascensia
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Menarini
  • MORE
Table Of Contents I
List Of Figures Iv
List Of Charts Vi
Executive Summary
European Market For Diabetes Monitoring, Treatment And Drug Delivery
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History
Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Disease Overview
2.1 Introduction
2.1.1 Types Of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated With Type 1 And Type 2 Diabetes
2.1.4 Signs And Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
Country Profiles
3.1 Introduction
3.1.1 Population
3.1.2 Gdp Per Capita
3.1.3 Units
3.2 Germany
3.3 France
3.4 United Kingdom
3.5 Italy
3.6 Spain
3.7 Benelux
3.8 Scandinavia
3.9 Austria
3.10 Switzerland
3.11 Portugal
Continuous Glucose Monitoring Market
4.1 Introduction
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Total Cgm Market
4.3.2 Cgm System Market
4.3.3 Cgm Sensor Market
4.3.4 Emerging Markets: Non-Invasive Cgm
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis
Abbreviations

Chart 1 1: Diabetes Diagnosis, Treatment and Drug Delivery, Europe, 2012 – 2022
Chart 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Market Overview, Europe, 2012 & 2022
Chart 3 1: Country Profile, Germany, 2015
Chart 3 2: Country Profile, France, 2015
Chart 3 3: Country Profile, United Kingdom, 2015
Chart 3 4: Country Profile, Italy, 2015
Chart 3 5: Country Profile, Spain, 2015
Chart 3 6: Country Profile, Benelux, 2015
Chart 3 7: Country Profile, Scandinavia, 2015
Chart 3 8: Country Profile, Austria, 2015
Chart 3 9: Country Profile, Switzerland, 2015
Chart 3 10: Country Profile, Portugal, 2015
Chart 4 1: Total CGM Market by Segment, Europe, 2015
Chart 4 2: Total CGM Market Breakdown, Europe, 2022
Chart 4 3: Total CGM Market Breakdown, Europe, 2022
Chart 4 4: Total CGM System Market, Europe, 2012 – 2022 (€M)
Chart 4 5: CGM System Market, Europe, 2012 – 2022
Chart 4 6: CGM Sensor Market, Europe, 2012 – 2022
Chart 4 7: Leading Competitors, CGM Market, Europe, 2015

Figure 1 1: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2)
Figure 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2)
Figure 1 3: Companies Researched in this Report, Europe, 2015
Figure 1 4: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (1 of 2)
Figure 1 5: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (2 of 2)
Figure 1 6: Recent Events in the Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2016
Figure 2 1: Major Types of Diabetes and Related Pathologies, Europe, 2015
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, Europe, 2015
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, Europe, 2015
Figure 4 1: Total CGM Market by Segment, Europe, 2012 – 2022 (€M)
Figure 4 2: Total CGM Market by Segment, Europe, 2012 – 2022 (US$M)
Figure 4 3: Total CGM Market, Europe, 2012 – 2022 (€ and US$)
Figure 4 4: CGM System Market, Europe, 2012 – 2022 (€ and US$)
Figure 4 5: Units Sold by Country, CGM System Market, Europe, 2012 – 2022
Figure 4 6: Average Selling Price by Country, CGM System Market, Europe, 2012 – 2022 (€)
Figure 4 7: Average Selling Price by Country, CGM System Market, Europe, 2012 – 2022 (US$)
Figure 4 8: Market Value by Country, CGM System Market, Europe, 2012 – 2022 (€M)
Figure 4 9: Market Value by Country, CGM System Market, Europe, 2012 – 2022 (US$M)
Figure 4 10: CGM Sensor Market, Europe, 2012 – 2022 (€ and US$)
Figure 4 11: Units Sold by Country, CGM Sensor Market, Europe, 2012 – 2022
Figure 4 12: Average Selling Price by Country, CGM Sensor Market, Europe, 2012 – 2022 (€)
Figure 4 13: Average Selling Price by Country, CGM Sensor Market, Europe, 2012 – 2022 (US$)
Figure 4 14: Market Value by Country, CGM Sensor Market, Europe, 2012 – 2022 (€M)
Figure 4 15: Market Value by Country, CGM Sensor Market, Europe, 2012 – 2022 (US$M)
Figure 4 16: Drivers and Limiters, CGM Market, Europe, 2015
Figure 4 17: Leading Competitors, CGM Market, Europe, 2015
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Ascensia
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Menarini
  • MORE
Continuous glucose monitoring (CGM) allows for a more accurate reading of how blood glucose levels fluctuate throughout the day by measuring interstitial glucose levels on a continuous basis and estimating blood glucose levels based on these readings.

The CGM system is typically made up of three components: a glucose sensor, transmitter and receiver. The sensor is inserted under the skin into the interstitial fluid and held with an adhesive. Sensors are typically sold in groups of four and are labeled for three to seven days of use, depending on the manufacturer. A transmitter takes the glucose reading from the sensor and wirelessly sends it to a small, hand-held receiver. If glucose levels are too low or high, the receiver warns the patient. Some manufacturers have even built-in a threshold audible alarm as a fixed safety feature when the patient approaches levels below 55 mg/dL, at which point the patient is still interactive but severely hypoglycemic.
Note: Product cover images may vary from those shown
5 of 5
Novo Nordisk
Sanofi
Roche
Johnson & Johnson
Eli Lilly
Abbott
Ascensia
Becton Dickinson
Medtronic
Menarini
DexCom
Ypsomed
Insulet
Artsana
B. Braun
Terumo
Others include: Abbott, AgaMatrix, Artsana, Apollo, BBI Healthcare, B. Braun, Berger, Beurer, Boehringer Ingelheim, Cellnovo, Codan, Comfort Point, Dario Health, Elektronika, Entra Health Systems, GlucoRx, GlucoZen, Infopia, Medtronic, MED TRUST, Medisana, Menarini, Merck Serono, MSP bodmann, Neon Diagnostics, NordicInfu Care, Novalab Ibérica, Novico, Owen Mumford, Pentaferte, Roche, Sanofi, SD BIOSENSOR, SFM Medical, Smiths Medical, Spirit Healthcare, Sooil, Trividia Health, Ypsomed, etc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll